The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway
- PMID: 29805510
- PMCID: PMC5958754
- DOI: 10.3892/etm.2018.6052
The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway
Abstract
The action mechanism of long non-coding ribonucleic acid-homeobox transcript antisense ribonucleic acid (lncRNA-HOTAIR) in the regulation of the Wnt signaling pathway on the drug resistance of non-small cell lung cancer was investigated. Forty eight patients with non-small cell lung cancer, who were treated with cisplatin (DDP) as neoadjuvant chemotherapy, were selected from the specimen bank of the Department of Pathology of Peking Union Medical College Hospital. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect the messenger RNA (mRNA) level of lncRNA-HOTAIR in cancer and cancer-adjacent tissues. The correlation curve of the expression of lncRNA-HOTAIR with the overall survival (OS) was plotted using the Kaplan-Meier method. NCI-H1299 DDP-resistant cell lines were constructed, and the half maximal inhibitory concentration (IC50) value was measured. The expression of lnc-HOTAIR in NCI-H1299/DDP cells was detected by the target interference of small interfering RNA (siRNA). The effect of si-HOTAIR on cell resistance was detected by Cell Counting Kit-8 (CCK-8). Western blot analysis was used to detect the effects of si-HOTAIR on multidrug resistance proteins, multidrug resistance-associated protein 1 (MRP1) and multidrug resistance 1 (MDR1), and Wnt signaling pathways, Wnt3a, adenomatous polyposis coli (APC) and β-catenin. The mRNA level of lncRNA-HOTAIR in cancer tissues was significantly higher than that in cancer-adjacent tissues (P<0.05), and the high expression of lncRNA-HOTAIR indicated that the OS of patients was shortened (P<0.05). The IC50 of NCI-H1299/DDP cells inhibiting DDP was 127.82 µM, which was significantly higher than that of parental NCI-H1299 cells (IC50=8.40 µM) (P<0.05). si-HOTAIR interference significantly decreased the sensitivity of cells to DDP, the IC50 of cells was decreased from 131.85 to 44.34 µM (P<0.05), the expression levels of MRP1 and MDR1 were significantly decreased, and the activation of Wnt signaling pathway was significantly inhibited (P<0.05). Thus, lncRNA-HOTAIR plays an important role in the occurrence and development of non-small cell lung cancer, and it may be an important factor in the clinical prognosis of patients with non-small cell lung cancer.
Keywords: Wnt signaling pathway; drug resistance; lncRNA-HOTAIR; non-small cell lung cancer.
Figures







Similar articles
-
[Effect of LncRNA HOTAIR on the proliferation, apoptosis and drug resistance of Wilms tumor cells through Wnt/β-catenin signaling pathway].Zhonghua Zhong Liu Za Zhi. 2021 Jul 23;43(7):769-774. doi: 10.3760/cma.j.cn112152-20191227-00846. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34289571 Chinese.
-
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629. doi: 10.1016/j.ijbiomac.2017.10.154. Epub 2017 Oct 26. Int J Biol Macromol. 2018. PMID: 29080815
-
LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4879-4887. doi: 10.26355/eurrev_201808_15624. Eur Rev Med Pharmacol Sci. 2018. PMID: 30070323
-
The HOTAIR lncRNA: A remarkable oncogenic promoter in human cancer metastasis.Oncol Lett. 2021 Apr;21(4):302. doi: 10.3892/ol.2021.12563. Epub 2021 Feb 17. Oncol Lett. 2021. PMID: 33732378 Free PMC article. Review.
-
The role of HOTAIR in the modulation of resistance to anticancer therapy.Front Mol Biosci. 2024 Jun 3;11:1414651. doi: 10.3389/fmolb.2024.1414651. eCollection 2024. Front Mol Biosci. 2024. PMID: 38887279 Free PMC article. Review.
Cited by
-
Long non-coding RNAs regulation of therapeutic resistance.Cancer Drug Resist. 2019 Sep 19;2(3):550-567. doi: 10.20517/cdr.2019.58. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582574 Free PMC article. Review.
-
Exosomal Long Non-Coding RNAs in Lung Diseases.Int J Mol Sci. 2020 May 19;21(10):3580. doi: 10.3390/ijms21103580. Int J Mol Sci. 2020. PMID: 32438606 Free PMC article. Review.
-
Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.Hum Cell. 2020 Jul;33(3):850-858. doi: 10.1007/s13577-020-00373-3. Epub 2020 May 25. Hum Cell. 2020. PMID: 32452013
-
Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.Oncol Lett. 2019 Nov;18(5):4798-4808. doi: 10.3892/ol.2019.10808. Epub 2019 Sep 5. Oncol Lett. 2019. PMID: 31611990 Free PMC article.
-
Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.Cancer Drug Resist. 2021 Jun 19;4(2):424-452. doi: 10.20517/cdr.2020.114. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582031 Free PMC article. Review.
References
-
- Hill C. Cancer prevention and screening. Bull Cancer. 2013;100:547–554. (In French) - PubMed
-
- Ettinger DS, Akerley W, Borghaei H. Elemene increases autophagic apoptosis and drug sensitivity in human cisplatin (DDP)-resistant lung cancer cell line SPC-A-1/DDP by inducing Beclin-1 expression. Oncol Res Featuring Preclinical Clin Cancer Ther. 2017;4:502–510. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials